Home / Business and Economy / Insider Sells $2M in MannKind Stock to Cover Taxes
Insider Sells $2M in MannKind Stock to Cover Taxes
21 Jul
Summary
- EVP Sanjay R. Singh sold 46,795 MannKind shares on July 15, 2026.
- Sale covered tax liabilities from restricted stock units vested in May 2023.
- Singh retains an ownership stake of 479,000 MannKind shares.
On July 15, 2026, Sanjay R. Singh, Executive Vice President of Technical Operations at MannKind Corporation, disposed of 46,795 shares of common stock. This sale was an automated execution to settle tax liabilities stemming from restricted stock units granted in May 2023.
The performance criteria for these awards included the company's stock price remaining above the grant-date level and achieving a total shareholder return at the 41.5th percentile of the Russell 3000 Pharmaceutical & Biotechnology Index. Despite performance objectives being met at 83% of target, resulting in a total delivery of 70,550 shares, 14,450 shares were forfeited. The shares sold were specifically to satisfy statutory tax requirements.
Following this transaction, Singh maintains a direct ownership of 479,000 shares, valued at approximately $2 million based on the July 15, 2026 closing price of $4.09 per share. MannKind Corporation, a biopharmaceutical firm focused on respiratory-delivered treatments, ties its equity incentives to product commercialization like Afrezza and Thyquidity.
